Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
Year: 2020
Type: review
Abstract: While colorectal cancers (CRC) are paradigmatic tumors invaded by effector memory lymphocytes, the mechanisms accounting for the relative resistance of MSI negative CRC to immunogenic cell death mediated by oxaliplatin and immune checkpoint inhibitors has remained an open conundrum. Here, we propose the viewpoint where its microenvironmental contexture could be explained -at least in part- by macroenvironmental cues constituted by the complex interplay between the epithelial barrier, its microbial ecosystem, and the local immune system. Taken together this dynamic ménage-à-trois offers novel coordinated actors of the humoral and cellular immune responses actionable to restore sensitivity to immune checkpoint inhibition. Solving this paradox involves breaking tolerance to crypt stem cells by inducing the immunogenic apoptosis of ileal cells in the context of an ileal microbiome shifted towards immunogenic bacteria using cytotoxicants. This manoeuver results in the elicitation of a productive Tfh and B cell dialogue in mesenteric lymph nodes culminating in tumor-specific memory CD8+ T cell responses sparing the normal epithelium.
Source: Frontiers in Immunology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: colorectal cancer, microsatellite instability, immunogenic cell death, oxaliplatin resistance, immune checkpoint inhibitors, tumor microenvironment, gut microbiota, epithelial barrier function, crypt stem cells, T follicular helper cells, B cells, mesenteric lymph nodes, memory CD8+ T cells, immune tolerance
Open Access status: gold
Estimated APC paid: $2,950
Funders: Cancer Prevention and Research Institute of Texas, Association pour la Recherche sur le Cancer, Seerave Foundation, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Assistance Publique - Hôpitaux de Paris, Fondation pour la Recherche Médicale, Ligue Contre le Cancer, Institut National Du Cancer, Cancéropôle Ile de France, Servier, Horizon 2020 Framework Programme, Labex Immuno-Oncology
OpenAlex ID: W3111618254
